Mindray acquires 75% stake in DiaSys Diagnostic Systems

Shenzhen Mindray Bio-Medical Electronics acquired a 75% stake in DiaSys Diagnostic Systems GmbH, a German specialist in diagnostic system solutions. The deal aims to support DiaSys's global supply platform and expand Mindray's presence in clinical chemistry.

“Freshfields advised Shenzhen Mindray Bio-Medical Electronics Co., Ltd. on the acquisition of a 75% stake in DiaSys Diagnostic Systems GmbH.”freshfields.com

• 1 source
• freshfields.comFreshfields advises Mindray on the acquisition of a majority interest in DiaSys | FreshfieldsAug 1, 2023

Summarized from public sources; check the original articles before acting on it.